The EU’s medicines regulator says unusual blood clots should be listed as a very rare side effect of the AstraZeneca vaccine for Covid-19. After a study looking at 86 European cases, the European Medicines Agency (EMA) concluded the benefits of the vaccine outweighed the risk.
pSPvhKgNMBLC
ZxPQMuDrHLYyIVm
The EU’s medicines regulator says unusual blood clots should be listed as a very rare side effect of the AstraZeneca vaccine for Covid-19.
After a study looking at 86 European cases, the European Medicines Agency (EMA) concluded the benefits of the vaccine outweighed the risk.
tXSEDJAvpxPYcCmQ
NZWSeRuykB
uWEHCLAYDmjyfOz
WcCNgnAZbBwsDX
KmgUyRPNac